|
Volumn 301, Issue 1, 2002, Pages 217-222
|
Influence of porcine Actinobacillus pleuropneumoniae infection and dexamethasone on the pharmacokinetic parameters of enrofloxacin
b a a b a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CIPROFLOXACIN;
DEXAMETHASONE;
ENROFLOXACIN;
ACTINOBACILLUS PLEUROPNEUMONIAE;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ARTICLE;
BACTERIAL INFECTION;
CONTROLLED STUDY;
CREATININE CLEARANCE;
DOSE RESPONSE;
DRUG CLEARANCE;
DRUG DISTRIBUTION;
DRUG HALF LIFE;
DRUG METABOLISM;
INFLAMMATION;
KIDNEY CLEARANCE;
METABOLITE;
NONHUMAN;
PRIORITY JOURNAL;
STEADY STATE;
SWINE;
TREATMENT PLANNING;
ACTINOBACILLUS INFECTIONS;
ACTINOBACILLUS PLEUROPNEUMONIAE;
ANIMALS;
ANTI-INFECTIVE AGENTS;
ANTI-INFLAMMATORY AGENTS;
AREA UNDER CURVE;
BIOTRANSFORMATION;
CHROMATOGRAPHY, HIGH PRESSURE LIQUID;
CIPROFLOXACIN;
CREATININE;
DEXAMETHASONE;
DRUG INTERACTIONS;
FLUOROQUINOLONES;
MALE;
QUINOLONES;
SWINE;
SWINE DISEASES;
|
EID: 0036200938
PISSN: 00223565
EISSN: None
Source Type: Journal
DOI: 10.1124/jpet.301.1.217 Document Type: Article |
Times cited : (20)
|
References (17)
|